1. Home
  2. WAVE vs PPBT Comparison

WAVE vs PPBT Comparison

Compare WAVE & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eco Wave Power Global AB (publ)

WAVE

Eco Wave Power Global AB (publ)

HOLD

Current Price

$6.16

Market Cap

43.3M

Sector

Utilities

ML Signal

HOLD

Logo Purple Biotech Ltd.

PPBT

Purple Biotech Ltd.

HOLD

Current Price

$0.76

Market Cap

7.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WAVE
PPBT
Founded
2011
2010
Country
Israel
Israel
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.3M
7.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
WAVE
PPBT
Price
$6.16
$0.76
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
12.6K
784.3K
Earning Date
11-12-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$168,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$400.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.41
$0.53
52 Week High
$17.38
$5.20

Technical Indicators

Market Signals
Indicator
WAVE
PPBT
Relative Strength Index (RSI) 32.71 45.42
Support Level $6.39 $0.78
Resistance Level $7.00 $0.87
Average True Range (ATR) 0.31 0.06
MACD -0.04 -0.01
Stochastic Oscillator 6.92 14.25

Price Performance

Historical Comparison
WAVE
PPBT

About WAVE Eco Wave Power Global AB (publ)

Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.

Share on Social Networks: